placeholder image
S. A. Irving All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • 18 Years - VISION and IVY Networks, September 2023-January 2024
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 states, June 2021-March 2023
    Clinical Infectious Diseases. 2024
  • Risk of COVID-19 hospitalization and protection associated with mRNA vaccination among US adults with psychiatric disorders
    Influenza and other respiratory viruses. 2024
  • Vaccine effectiveness against pediatric influenza-A-associated urgent care, emergency department, and hospital encounters during the 2022-2023 season: VISION Network
    Clinical Infectious Diseases. 2024
  • Accuracy of COVID-19-like illness diagnoses in electronic health record data: retrospective cohort study
    JMIR formative research. 2023
  • Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months
    Academic Pediatrics. 2023
  • COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion
    JAMA network open. 2023
  • COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion
    American Journal of Epidemiology. 2023
  • Effectiveness of BNT162b2 COVID-19 vaccination in children and adolescents
    Pediatrics. 2023
  • Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: an observational study of real-world data across 10 US states from August-December 2021
    Vaccine. 2023
  • Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023
    American Journal of Transplantation. 2023
  • Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods
    JAMA network open. 2023
  • Influenza vaccination among pregnant people before and during the coronavirus disease 2019 (COVID-19) pandemic
    Obstetrics and Gynecology. 2023
  • Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons
    Vaccine. 2023
  • Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study
    Lancet Reg Health Am. 2023
  • Patient and epidemiological factors associated with influenza testing in hospitalized adults with acute respiratory illnesses, 2016-2017 to 2019-2020
    Open forum infectious diseases. 2023
  • Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance
    Journal of Infectious Diseases. 2023
  • Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19--VISION Network, August 2021 to March 2022
    Journal of Infectious Diseases. 2023
  • Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness
    Clinical Infectious Diseases. 2023
  • Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink
    Vaccine. 2023
  • Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines
    Vaccine. 2023
  • Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network
    Journal of Infectious Diseases. 2023
  • Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults - VISION Network, nine states, September-November 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated - VISION Network, 10 states, December 2021-June 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance - VISION Network, 10 states, December 2021-August 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults - VISION Network, 10 states, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-nine states, January-September 2021
    American Journal of Transplantation. 2022
  • Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States
    JAMA network open. 2022
  • Monitoring vaccine safety using the vaccine safety Datalink: assessing capacity to integrate data from Immunization Information systems
    Vaccine. 2022
  • Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Relative risks of COVID-19-associated hospitalizations and clinical outcomes by age and race/ethnicity-March 2020-March 2021
    Open forum infectious diseases. 2022
  • Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
    BMJ (Clinical research ed.). 2022
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Developing algorithms for identifying major structural birth defects using automated electronic health data
    Pharmacoepidemiology and Drug Safety. 2021
  • Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
    New England Journal of Medicine. 2021
  • Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination
    Vaccine. 2021
  • Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
    Therapeutic advances in drug safety. 2021
  • Uptake and safety of hepatitis A vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2019
  • 2015-2016 Vaccine effectiveness of live attenuated and inactivated influenza vaccines in children in the United States
    Clinical Infectious Diseases. 2018
  • Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents
    Pharmacoepidemiology and Drug Safety. 2018
  • Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2018
  • Risk of anaphylaxis after vaccination in children and adults
    Journal of Allergy and Clinical Immunology. 2016
  • Vaccinations given during pregnancy, 2002-2009: a descriptive study
    American Journal of Preventive Medicine. 2014
  • Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink
    Vaccine. 2013
  • Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Pharmacoepidemiology and Drug Safety. 2013
  • Trivalent inactivated influenza vaccine and spontaneous abortion
    Obstetrics and Gynecology. 2013
  • Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Influenza and other respiratory viruses. 2012
  • H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    American Journal of Preventive Medicine. 2011
  • Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine
    Pediatric Infectious Disease Journal. 2010
  • Contact
    full name
  • S. A. Irving
  • Quick Info
     
    Collaboration